JP2025507292A5 - - Google Patents

Info

Publication number
JP2025507292A5
JP2025507292A5 JP2024546071A JP2024546071A JP2025507292A5 JP 2025507292 A5 JP2025507292 A5 JP 2025507292A5 JP 2024546071 A JP2024546071 A JP 2024546071A JP 2024546071 A JP2024546071 A JP 2024546071A JP 2025507292 A5 JP2025507292 A5 JP 2025507292A5
Authority
JP
Japan
Application number
JP2024546071A
Other languages
Japanese (ja)
Other versions
JP2025507292A (ja
JPWO2023150535A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/061727 external-priority patent/WO2023150535A1/en
Publication of JP2025507292A publication Critical patent/JP2025507292A/ja
Publication of JPWO2023150535A5 publication Critical patent/JPWO2023150535A5/ja
Publication of JP2025507292A5 publication Critical patent/JP2025507292A5/ja
Pending legal-status Critical Current

Links

JP2024546071A 2022-02-02 2023-02-01 プロテインチロシンホスファターゼ阻害剤およびその使用 Pending JP2025507292A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263305786P 2022-02-02 2022-02-02
US63/305,786 2022-02-02
PCT/US2023/061727 WO2023150535A1 (en) 2022-02-02 2023-02-01 Protein tyrosine phosphatase inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2025507292A JP2025507292A (ja) 2025-03-18
JPWO2023150535A5 JPWO2023150535A5 (https=) 2026-02-09
JP2025507292A5 true JP2025507292A5 (https=) 2026-02-09

Family

ID=87552989

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546071A Pending JP2025507292A (ja) 2022-02-02 2023-02-01 プロテインチロシンホスファターゼ阻害剤およびその使用

Country Status (7)

Country Link
US (1) US20250136564A1 (https=)
EP (1) EP4472976A4 (https=)
JP (1) JP2025507292A (https=)
CN (1) CN119137117A (https=)
AR (1) AR128418A1 (https=)
TW (1) TW202337459A (https=)
WO (1) WO2023150535A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20240360A (es) * 2022-02-02 2024-10-01 Nerio Therapeutics Inc Inhibidores de proteína tirosina fosfatasa y usos de estos
CN120981456A (zh) 2023-05-24 2025-11-18 金橘生物科技公司 杂环化合物及其用途
WO2025030008A1 (en) * 2023-08-02 2025-02-06 Nerio Therapeutics, Inc. Protein tyrosine phosphatase inhibitor combinations
CN120004876B (zh) * 2023-11-16 2026-02-06 英矽智能科技(上海)有限公司 蛋白酪氨酸磷酸酶抑制剂及其应用
CN117343052B (zh) * 2023-12-04 2024-02-06 英矽智能科技(上海)有限公司 蛋白酪氨酸磷酸酶抑制剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA94724C2 (en) * 2005-12-08 2011-06-10 Новартис Аг Thiadiazolidinone derivatives as antidiabetic agents
UA94921C2 (en) * 2005-12-08 2011-06-25 Новартис Аг 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
RU2015140066A (ru) * 2013-02-22 2017-03-30 Мерк Шарп И Доум Корп. Противодиабетические бициклические соединения
PE20252767A1 (es) * 2019-03-14 2025-12-22 Calico Life Sciences Llc Inhibidores de la proteina tirosina fosfatasa y metodos para usarlos
CA3191842A1 (en) * 2020-09-11 2022-03-17 Calico Life Sciences Llc Protein tyrosine phosphatase inhibitors and methods of use thereof
CN117279913A (zh) * 2021-03-11 2023-12-22 金橘生物科技公司 杂环化合物及其用途

Similar Documents

Publication Publication Date Title
JP2024509962A5 (https=)
JP2025507292A5 (https=)
BR102022025291A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022005961U2 (https=)
BY13163U (https=)
BY13156U (https=)
BY13172U (https=)
BY13151U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13165U (https=)
BY13164U (https=)
BY13176U (https=)